Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» gastric cancer
gastric cancer
Macrogenics scoops its ASCO bounce
EP Vantage
Fri, 05/8/20 - 10:20 am
ASCO 2020
Macrogenics
margetuximab
cancer
breast cancer
gastric cancer
After $105M funding round, ALX Oncology nabs FDA fast-track tag for cancer hopeful
Fierce Biotech
Tue, 02/18/20 - 10:55 am
ALX Oncology
fast rack
FDA
head and neck cancer
ALX148
gastric cancer
Breast cancer approval in tow, AstraZeneca, Daiichi armed antibody scores in key gastric cancer study
Endpoints
Mon, 01/27/20 - 10:44 am
AstraZeneca
breast cancer
Daiichi Sankyo
trastuzumab deruxtecan
gastric cancer
FDA grants breakthrough status to AI-based gastric cancer diagnostic
Medtech Dive
Tue, 11/12/19 - 08:11 pm
gastric cancer
AI Medical Service
diagnostics
FDA
artificial intelligence
devices
Merck KGaA, Pfizer drug fails to meet endpoints in gastric cancer trial
Marketwatch
Fri, 11/8/19 - 10:45 am
Merck KGaA
Pfizer
Bavencio
clinical trials
gastric cancer
Leap zeroes in on subgroup for DKN-01, Keytruda combo
BioCentury
Wed, 08/7/19 - 11:32 pm
Leap Therapeutics
DKN-01
Keytruda
gastric cancer
Keytruda PhIII failure in gastric cancer blights Merck's quest for frontline dominance
Endpoints
Fri, 04/26/19 - 10:14 am
Merck
Keytruda
gastric cancer
First Patient Dosed in Ph III Trial of Bemarituzumab for Advanced Gastric and Gastroesophageal Junction Cancers
CP Wire
Mon, 10/1/18 - 09:38 am
Five Prime
Zai Lab
bemarituzumab
gastric cancer
First Patient Dosed in Ph III Trial of Bemarituzumab for Advanced Gastric and Gastroesophageal Junction Cancers
Mon, 10/1/18 - 09:38 am
Five Prime
Zai Lab
bemarituzumab
gastric cancer
Immunicum AB Announces FDA Approval to Expand Ph Ib/II trial of Cancer Drug
CP Wire
Mon, 07/23/18 - 10:12 am
Immunicum
clinical trials
ilixadencel
head and neck cancer
non-small cell lung cancer
gastric cancer
Phase III Trial Data Demonstrates Significant Overall Survival Benefit of Lonsurf (trifluridine and tipiracil) in Patients with Metastatic Gastric Cancer
CP Wire
Thu, 06/21/18 - 10:13 am
Servier
Taiho Pharmaceutical
Lonsurf
gastric cancer
Phase III Trial Data Demonstrates Significant Overall Survival Benefit of Lonsurf (trifluridine and tipiracil) in Patients with Metastatic Gastric Cancer
Thu, 06/21/18 - 09:53 am
Servier
Taiho Pharmaceutical
Lonsurf
gastric cancer
Pfizer, Merck KGaA run into a severe setback as PD-L1 drug Bavencio fails in PhIII gastric cancer study
Endpoints
Tue, 11/28/17 - 10:11 am
Pfizer
Merck KGaA
Bavencio
anti-PD-L1
gastric cancer
Billionaire-backed Ganymed grabs ASCO spotlight with gastric cancer drug
Fierce Biotech
Sun, 06/5/16 - 12:05 pm
Ganymed
ASCO 2016
IMAB362
gastric cancer
ImmunoGen, Roche gastric cancer drug fails study
Yahoo/Reuters
Thu, 10/22/15 - 09:54 am
Immunogen
Roche
gastric cancer
clinical trials
Kadcyla
Gilead: No Big Deals
Barron's
Wed, 05/13/15 - 05:00 pm
Gilead Sciences
GS-5745
gastric cancer
MSD Announces First Presentation of Data on the Investigational Use of Pembrolizumab in Patients with Advanced Gastric Cancer at
Yahoo/BusinessWire
Sun, 09/28/14 - 10:10 am
Merck
Pembrolizumab
gastric cancer
Keytruda
Lilly's Cyramza shows survival benefit in gastro cancers
Pharma Times
Fri, 09/19/14 - 09:53 am
Eli Lilly
Cyramza
gastric cancer
Genentech granted FDA orphan status for gastric cancer treatment
Yahoo/Fly on the Wall
Fri, 05/2/14 - 09:53 am
Genentech
FDA
gastric cancer
cancer of the gastro-esophageal junction
orphan drugs
Ipatasertib
Lilly’s Gastric Cancer Drug Wins Approval From U.S. FDA
Bloomberg
Mon, 04/21/14 - 04:58 pm
Eli Lilly
gastric cancer
FDA
ramucirumab
Pages
« first
‹ previous
1
2
3
next ›
last »